Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Eli Lilly becomes first drugmaker to hit $1 trillion in market value
The pharmaceutical company’s success developing medicines for obesity has swelled its worth to levels associated with tech titans like Apple and Google and dwarfed that...
Recursion Pharmaceuticals Surpasses Third-Quarter Expectations, Announces Milestone with Roche - StocksToTrade
Recursion Pharmaceuticals Surpasses Third-Quarter Expectations, Announces Milestone with Roche StocksToTrade
The Ensign Group, Illumina, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know - MSN
The Ensign Group, Illumina, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know MSN
Eli Lilly becomes first drugmaker to hit $1 trillion in market value
The pharmaceutical company’s success developing medicines for obesity has swelled its worth to levels associated with tech titans like Apple and Google and dwarfed that...
Olema Pharmaceuticals (OLMA) Rethinks Competitive Edge After Roche’s Breast Cancer Trial Success - Yahoo Finance
Olema Pharmaceuticals (OLMA) Rethinks Competitive Edge After Roche’s Breast Cancer Trial Success Yahoo Finance
Roche’s fenebrutinib shows best-in-disease potential in MS - European Pharmaceutical Review
Roche’s fenebrutinib shows best-in-disease potential in MS European Pharmaceutical Review
Roche in ongoing discussions with US government over drug pricing, CEO says - Pharmaceutical Technology
Roche in ongoing discussions with US government over drug pricing, CEO says Pharmaceutical Technology
ADCs on the rise: MilliporeSigma, Lonza invest in manufacturing while BioNTech adds CMOs ahead of FDA filing - Pharmaceutical Technology
ADCs on the rise: MilliporeSigma, Lonza invest in manufacturing while BioNTech adds CMOs ahead of FDA filing Pharmaceutical Technology
Thermo Fisher acquires Sanofi’s steriles manufacturing site in US - Pharmaceutical Technology
Thermo Fisher acquires Sanofi’s steriles manufacturing site in US Pharmaceutical Technology
Ethris and Lonza focus on mRNA respiratory condition vaccines - Pharmaceutical Technology
Ethris and Lonza focus on mRNA respiratory condition vaccines Pharmaceutical Technology
Revolutionary approaches to drug design: how AI is transforming life sciences - Pharmaceutical Technology
Revolutionary approaches to drug design: how AI is transforming life sciences Pharmaceutical Technology
JPM 2025: Lonza shares outlook on CHI exit and acquisition strategy - Pharmaceutical Technology
JPM 2025: Lonza shares outlook on CHI exit and acquisition strategy Pharmaceutical Technology
Directory ribbon
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page